Evaluation of VEGF and IGF-1 plasma levels in preterm infants - Potential correlation with retinopathy of prematurity, clinical implications;Ocena stȩżenia VEGF i IGF-1 we krwi obwodowej wcześniaków - Próba korelacji z rozwojem retinopatii wczeşniaczej, implikacje kliniczne

Klinika Oczna

Volumn 111, Issue 10-12, 2009, Pages 302-306

  Machalińska, Anna ^a,c   Modrzejewska, Monikań ^b   Dziedziejko, Violetta ^c   Kotowski, Maciej ^c   Safranow, Krzysztof ^c   Herbowska, Aleksandra ^c   Karczewicz, Danuta ^b  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b Akademii Medycznej   (Poland)

^c Akademii Medycznej   (Poland)

Author keywords

IGF 1; Retinal neovascularization; Retinopathy of prematurity; VEGF

Indexed keywords

BIOLOGICAL MARKER; SOMATOMEDIN C; VASCULOTROPIN A;

ARTICLE; BLOOD; HUMAN; NEWBORN; REFERENCE VALUE; RETROLENTAL FIBROPLASIA;

BIOLOGICAL MARKERS; HUMANS; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR I; REFERENCE VALUES; RETINOPATHY OF PREMATURITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77950355935     PISSN: 00232157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Lad EM, Nguyen TC, Morton JM, Moshfeghi DM: Retinopathy of prematurity in the United States. Br J Ophthalmol 2008, 92, 320-325. (Pubitemid 351363521)
2. Modrzejewska M: Retinopatia wcześniaków - patogeneza i wystepowanie. Annalaes Medicae Stetinensis 2006, Tom LII, Nr 1, 67-72.
3. Chen J, Smith LE: Retinopathy of prematurity (Review). Angiogenesis 2007, 10, 133-140.
4. Fruttiger M.: Development of the retinal vasculature (Review). Angiogenesis 2007, 10, 77-88.
5. Iternational Committee for the Classification of Retinopathy of Prematurity: The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005, 123, 991-999.
6. Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME: Vascular endothelial growth factor in eye disease. Prog Retin Eye Res 2008, 27, 331-371.
7. Sonmez K, Drenser KA, Capone A Jr, Trese MT: Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity. Ophthalmology. 2008, 115, 1065-1070.
8. Travassos A, Teixeira S, Ferreira P, Regadas I, Travassos AS, Esperancinha FE, Prieto I, Pires G, van Velze R, Valido A, Machado M: Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity. Ophthalmic Surg Lasers Imaging. 2007, 38, 233-237. (Pubitemid 46953791)
9. Hellström A, Carlsson B, Niklasson A, Segnestam K, Boguszewski M, de Lacerda L, Savage M, Svensson E, Smith L, Weinberger D, Albertsson Wikland K, Laron Z: IGF-I is critical for normal vascularization of the human retina. J Clin Endocrinol Metab 2002, 87, 3413-3416. (Pubitemid 34816398)
10. Hellstrom A, Perruzzi C, Ju M, Engstrom E, Hard AL, Liu JL, Albertsson-Wikland K, Carlsson B, Niklasson A, Sjodell L, Le Roith D, Senger DR, Smith LE: Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci USA 2001, 98, 5804-5808. (Pubitemid 32435723)
11. Hellström A, Engström E, Hård AL, Albertsson-Wikland K, Carlsson B, Niklasson A, Löfqvist C, Svensson E, Holm S, Ewald U, Holmström G, Smith LE: Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics 2003, 112, 1016-1020. (Pubitemid 37339551)
12. Löfqvist C, Andersson E, Sigurdsson J, Engstrom E, Hård AL, Niklasson A, Smith LE, Hellström A: Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity. Arch Ophthalmol 2006, 124, 1711-1718. (Pubitemid 44913194)
13. Smith LE, Shen W, Perruzzi C, Soker S, Kinose F, Xu X, Robinson G, Driver S, Bischoff J, Zhang B, Schaeffer JM, Senger DR: Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 1999, 5, 1390-1395.